PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK - Perard, R.; Samyshkin, Y.; Guillermin, A.L.G. (Value in Health, 2011)